Hematology/Oncology

Hong DS, Gopal AK, Shoushtari AN, Patel SP, He AR, Doi T, Ramalingam SS, Patnaik A, Sandhu S, Chen Y, Davis CB, Fisher TS, Huang[...]

By sjmartinez • August 2, 2022

Wander SA, O'Brien N, Litchfield LM, O'Dea D, Morato Guimaraes C, Slamon DJ, Goel S. Targeting CDK4 and 6 in Cancer Therapy: Emerging Preclinical Insights[...]

By sjmartinez • August 2, 2022

Sun N, Zhang C, Lee YT, Tran BV, Wang J, Kim H, Lee J, Zhang RY, Wang JJ, Hu J, Zhang Z, Alsudaney MS, Hou[...]

By sjmartinez • July 31, 2022

Shiuan E, Sharma D, Ely EW, Moodabagil N, Tillman BF. Limb ischemia due to spontaneous heparin-induced thrombocytopenia as the primary presentation of acute COVID-19 infection.[...]

By sjmartinez • July 28, 2022

Breen EC, Sehl ME, Shih R, Langfelder P, Wang R, Horvath S, Bream JH, Duggal P, Martinson J, Wolinsky SM, Martínez-Maza O, Ramirez CM, Jamieson[...]

By rosaguerrero • July 27, 2022

Lee CI, Elmore JG. Cancer Risk Prediction Paradigm Shift: Using Artificial Intelligence to Improve Performance and Health Equity. J Natl Cancer Inst. 2022 Jul 25:djac143.[...]

By sjmartinez • July 25, 2022

Mao Z, Nesterenko PA, McLaughlin J, Deng W, Burton Sojo G, Cheng D, Noguchi M, Chour W, DeLucia DC, Finton KA, Qin Y, Obusan MB,[...]

By sjmartinez • July 25, 2022

Lee JT, Yang HH, Sanghoon Shin D, Srivatsan E, Basak S. In Vitro Effects of Permethrin on Sinonasal Epithelia. OTO Open. 2022 Jul 14;6(3):2473974X221109838. doi:[...]

By rosaguerrero • July 22, 2022

Othman T, Penaloza J, Zhang S, Daniel CE, Gaut D, Oliai C, Brem EA, Baweja A, Ly J, Reid J, Pinter-Brown L, Lee M, Abdulhaq[...]

By rosaguerrero • July 21, 2022

Shin DS, Park K, Garon E, Dubinett S. Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer. Semin Oncol. 2022 Jul 2:S0093-7754(22)00045-8. doi:[...]

By rosaguerrero • July 20, 2022